Bromisoval

CAS : 496-67-3

Ref. 3D-FB38229

Informations sur le produit

• Nom: Bromisoval
• Synonymes: N-(2-Bromo-3-methylbutanoyl)urea, (2-Bromo-3-methylbutanoyl)urea, (2R)-2-bromo-N-carbamoyl-3-methylbutanamide, (2S)-2-bromo-N-carbamoyl-3-methylbutanamide, (RS)-2-Bromoisovalerylurea, (α-Bromoisovaleryl)urea, 2-Bromo-3-methylbutyrylurea, 2-Bromoisovalerylurea, 2-bromo-N-carbamoyl-3-methylbutanamide, Abroval, Alluval, Alural, Bromaral, Bromcarbamide, Bromisovalerylurea, Bromisovalum, Bromizoval, Bromocarbamide, Bromoisovalum, Bromoval, Bromovalerocarbamide, Bromovaleroylurea, Bromovalerylurea, Bromoxil, Bromural, Bromuvan, Bromvalerylurea, Bromvaletone, Bromvalurea, Bromyl, Brovalin, Brovalurea, Brovarin, Butanamide, N-(aminocarbonyl)-2-bromo-3-methyl-, Calmotin, Dagrabromyl, Dibroluur, Dormigene, Isobromyl, N-(Aminocarbonyl)-2-bromo-3-methylbutanamide, Pivadorm, Pivadorn, Somnurol, Upiol, Urea, (2-bromo-3-methylbutyryl)-, Uvaleral, α-Bromisovalerylurea, α-Bromo-β-dimethylpropanoylurea, α-Bromoisovaleric acid ureide, α-Bromoisovaleroylurea

Description

Bromisoval is a drug that is used to treat symptoms of oxidative injury. It is a cytostatic drug, which inhibits the growth of epidermal cells in culture. Bromisoval has been shown to be toxic and inhibit protein synthesis in human serum and in pathogenic mechanisms. However, it does not cause toxicity or inhibit protein synthesis in bowel disease. Bromisoval has also been shown to have anti-inflammatory properties, which may be due to its inhibition of prostaglandin synthesis.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 223.07 g/mol
• Formule: C₆H₁₁BrN₂O₂
• Degré de pureté: Min. 95%